Simplify Logo

Full-Time

Associate Director or Director

Dmpk

Posted on 6/27/2024

Kymera Therapeutics

Kymera Therapeutics

201-500 employees

Develops small molecule protein degraders for diseases

Biotechnology

Senior, Expert

Belmont, MA, USA

Category
Computational Biology
Public Health
Biology Lab & Research
Biology & Biotech
Requirements
  • MSc or PhD in Drug Metabolism, Pharmacokinetics, Pharmaceutical Sciences, Pharmacology, or related disciplines
  • 15+ years (with MSc) or 5 - 10 years (with PhD) of relevant experience in the Pharmaceutical/Biotech industry
  • Prior experience as a core DMPK project team representative on a multifunctional team is required
  • In-depth understanding and strategic application of all PK/ADME assays, methods and models
  • Strong understanding of DMPK, PK/PD modeling, human PK, efficacious dose, and DDI prediction strategies
  • Expertise in managing CROs, robust knowledge of relevant regulatory guidances
  • Proficiency in Phoenix WinNonlin highly desired. Experiences with PBPK modeling are a plus
  • Passion for data-driven analysis, and strongly developed business-of-science thinking
  • Excellence in analytical, organizational, and communication skills
  • Ability to thrive in a fast-paced, highly matrixed environment
Responsibilities
  • Represent DMPK function as core project team member
  • Conduct basic PK and PK/PD modeling
  • Design and implementation of DMPK strategies for NCE optimization and characterization
  • Outstanding, proactive collaboration with all team functions
  • Manage interactions with CROs to ensure high quality and on-time execution of DMPK studies
  • Author and review relevant sections of regulatory documents
  • Contribute to internal and external presentation/publication strategy

Kymera Therapeutics is at the forefront of utilizing its proprietary Pegasus platform to develop small molecule protein degraders, targeting specific disease-causing proteins in critical areas like immunology-inflammation and oncology. This offers a dynamic workplace with a focus on cutting-edge technology and treatments that could drastically improve patient outcomes in significant disease domains. The company's commitment to advancing medical science and its technical proficiency provides a stimulating environment for professionals passionate about making a tangible impact on healthcare.

Company Stage

IPO

Total Funding

$879M

Headquarters

Watertown, Massachusetts

Founded

2016

Growth & Insights
Headcount

6 month growth

0%

1 year growth

5%

2 year growth

30%